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A B S T R A C T
Background
Age-related cataract is one of the leading causes of blindness worldwide. Therefore, it is important to establish the most effective surgical
technique for cataract surgery.
Objectives
The aim of this review is to examine the effects of two types of cataract surgery for age-related cataract: phacoemulsification and
extracapsular cataract extraction (ECCE).
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 4),
Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE
(January 1946 to May 2013), EMBASE (January 1980 to May 2013), Latin American and Caribbean Literature on Health Sciences
(LILACS) (January 1982 to May 2013), Web of Science Conference Proceedings Citation Index - Science (CPCI-S) (January 1970
to May 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov)
and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or
language restrictions in the electronic searches for trials. We last searched the electronic databases on 13 May 2013.
Selection criteria
We included randomised controlled trials of phacoemulsification compared to ECCE for age-related cataract.
Data collection and analysis
Two authors independently selected and assessed all studies. We defined two primary outcomes: ’good functional vision’ (presenting
visual acuity of 6/12 or better) and ’poor visual outcome’ (best corrected visual acuity of less than 6/60) at three and 12 months after
surgery. We also collected data on intra and postoperative complications, and the cost of the procedures.
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Main results
We included 11 trials in this review with a total of 1228 participants, ranging from age 45 to 94. The studies were generally at unclear
risk of bias due to poorly reported trial methods. No study reported presenting visual acuity, so we report both uncorrected (UCVA)
and best corrected visual acuity (BCVA). Studies varied in visual acuity assessment methods and time frames at which outcomes were
reported. Participants in the phacoemulsification group were more likely to achieve UCVA of 6/12 or more at three months (risk ratio
(RR) 1.81, 95% confidence interval (CI) 1.36 to 2.41, two studies, 492 participants) and one year (RR 1.99, 95% CI 1.45 to 2.73,
one study, 439 participants). People in the phacoemulsification group were also more likely to achieve BCVA of 6/12 or more at three
months (RR 1.12, 95% CI 1.03 to 1.22, four studies, 645 participants) and one year (RR 1.06, 95% CI 0.99 to 1.14, one study, 439
participants), but the difference between the two groups was smaller. No trials reported BCVA less than 6/60 but three trials reported
BCVA worse than 6/9 and 6/18: there were fewer events of this outcome in the phacoemulsification group than the ECCE group at
both the three-month (RR 0.33, 95% CI 0.20 to 0.55, three studies, 604 participants) and 12-month time points (RR 0.62, 95% CI
0.36 to 1.05, one study, 439 participants). Three trials reported posterior capsule rupture: this occurred more commonly in the ECCE
group than the phacoemulsification group but small numbers of events mean the true effect is uncertain (Peto odds ratio (OR) 0.56,
95% CI 0.26 to 1.22, three studies, 688 participants). Iris prolapse, cystoid macular oedema and posterior capsular opacification were
also higher in the ECCE group than the phacoemulsification group. Phacoemulsification surgical costs were higher than ECCE in two
studies. A third study reported similar costs for phacoemulsification and ECCE up to six weeks postoperatively, but following this time
point ECCE incurred additional costs due to additional visits, spectacles and laser treatment to achieve a similar outcome.
Authors’ conclusions
Removing cataract by phacoemulsification may result in a better visual acuity compared to ECCE, with a lower complication rate.
The review is currently underpowered to detect differences for rarer outcomes, including poor visual outcome. The lower cost of
ECCE may justify its use in a patient population where high-volume surgery is a priority, however, there are a lack of data comparing
phacoemulsification and ECCE in lower-income settings.
P L A I N L A N G U A G E S U M M A R Y
Comparing two different techniques of removing cataracts
Cataract is a clouding of the lens in the eye and is one of the leading causes of blindness worldwide. The only method of treatment
for this condition is surgery to remove the opacified lens and to replace it with a new lens, usually made of plastic. There are various
surgical techniques for removing the lens, and in this review we compare two of them: phacoemulsification and extracapsular cataract
extraction (ECCE).
A searchwas performed of the literature inMay 2013 for studies comparing the two techniques and 11 randomised controlled trials were
identified which included a total of 1228 participants. These trials included participants with age-related cataract and were conducted
in Europe, South America and the Far East. We evaluated these for any biases that may have affected the data, extracted data according
to pre-determined criteria and performed analyses of the pooled data from all studies where possible.
There were few studies that reported outcomes which met our pre-defined criteria. The studies were generally at unclear risk of bias
due to poorly reported trial methods and the overall quality of the evidence for different outcomes ranged from moderate to very low.
Phacoemulsification gave superior results at both three and 12-month time points. Complications were higher in the ECCE group
than the phacoemulsification group. However, two out of three studies that reported costs indicated that ECCE was cheaper than
phacoemulsification.
In summary, on the basis of the few studies that reported outcomes that we could include in our analysis, visual outcomes were
better with phacoemulsification and complications were lower with this technique. However, ECCE was cheaper and in lower income
countries ECCE may therefore have a role in maximising the number of people that can be treated with limited resources.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Phacoemulsification compared with extracapsular cataract extraction for age-related cataract
Participant or population: people with age-related cataract
Settings: hospital
Intervention: phacoemulsification
Comparison: extracapsular cataract extraction
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
ECCE Phacoemulsification
Presenting visual acuity
>= 6/12
12 months after surgery
⊕⊕©©
low1,2
No trials reported present-
ing visual acuity; 1 trial
in a higher-income set-
ting reported uncorrected
and best corrected visual
acuity of 6/9 or better
at 12 months. Both were
in favour of phacoemul-
sification: UCVA RR 1.99
(95% CI 1.45 to 1.73),
BCVA RR 1.06 (95% CI 0.
99 to 1.14)
Best corrected visual
acuity <6/60
12 months after surgery
145 per 1000 90 per 1000
(52 to 152)
RR 0.62 (0.36 to 1.05) 439
(1)
⊕©©©
very low1,3,4
Only 1 study in a higher-
income setting reported
this outcome so the re-
sults may not apply in
lower-income settings
3
P
h
a
c
o
e
m
u
lsifi
c
a
tio
n
w
ith
p
o
ste
rio
r
c
h
a
m
b
e
r
in
tra
o
c
u
la
r
le
n
s
v
e
rsu
s
e
x
tra
c
a
p
su
la
r
c
a
ta
ra
c
t
e
x
tra
c
tio
n
(E
C
C
E
)
w
ith
p
o
ste
rio
r
c
h
a
m
b
e
r
in
tra
o
c
u
la
r
le
n
s
fo
r
a
g
e
-re
la
te
d
c
a
ta
ra
c
t
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
4
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Posterior capsule opaci-
fication 12 months after
surgery
300 per 1000 114 per 1000
(66 to 198)
RR 0.38 (0.22 to 0.66) 571
(2)
⊕⊕⊕©
moderate5
Posterior capsule opacifi-
cation was reported in 1
study (Katsimpris 2004)
(RR 0.23, 95% CI 0.09 to
0.58) and laser capsulo-
tomy in 1 study (MEHOX
2004) (RR 0.50, 95% CI
0.25 to 1.01) (I2 = 43%)
Other complications See comments 2 cases of retinal de-
tachment were reported
in MEHOX 2004, both
in the phacoemulsifica-
tion group (OR 7.04, 95%
CI 0.44 to 112.93)
Cystoid macular oedema
was reported in 2 stud-
ies and was more com-
mon in the ECCE group (
Katsimpris 2004; MEHOX
2004) (OR 0.29, 95 5 CI
0.10 to 0.86)
Endophthalmitis was re-
ported in MEHOX 2004
with 3 cases (1%) in
the phacoemulsification
group and 1 case (0.4%)
in the ECCE group
Quality of life See comments No data reported
Costs See comments Kara-Junior 2010 re-
ported a cost of surgery
of USD 242.23 for pha-
coemulsification and USD
155.50 for ECCE
MEHOX 2004 reported a
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cost of GBP 359.89 for
phacoemulsification and
GBP 367.57 for ECCE
Rizal 2003 reported a
cost of MYR 1978 for
phacoemulsification and
MYR 1664 for ECCE
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; ECCE: extracapsular cataract extraction; RR: risk ratio; OR: odds ratio; UCVA: uncorrected visual acuity
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
Assumed risk estimated from control group risk across studies.
1Downgraded for inconsistency: only one study so we were not able to assess consistency.
2Downgraded for indirectness: no study reported presenting visual acuity.
3Downgraded for imprecision: wide confidence intervals, effect uncertain.
4Downgraded for indirectness; cut-point <6/9 not <6/60.
5Downgraded for indirectness: majority of events come from study that measured laser capsulotomy rather than posterior capsule
opacification.
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B A C K G R O U N D
Description of the condition
Cataract is the opacification of the normally transparent lens of
the eye and occurs as a result of denaturation of lens proteins. This
cloudiness can cause a decrease in vision and may lead to eventual
blindness. Most cataracts are age-related. Initially, cataracts may
not affect vision if the cataract remains small or at the periphery
of the lens. If the cataract forms in the area of the lens directly
behind the pupil, vision may be significantly impaired. Changes
are not thought to be reversible and surgery is currently the only
treatment option, where the cataract is removed and a replacement
lens is inserted into the eye.
TheWorld Health Organization (WHO) estimated from a recent
global review of surveys that in 2002 37 million people worldwide
were blind (Passolini 2004; Resnikoff 2004) and that age-related
cataract remained the leading cause of blindness globally (as it was
in 1990). Fifty per cent of world blindness is thought to be due to
cataract and the majority of blinding cataract is found in develop-
ing countries. The contribution of cataracts to blindness globally
is likely to grow due to an ageing population and unsuccessful
attempts to control this blinding condition in low and middle-
income countries .
Blindness and severe visual impairment have a significant impact
on the socioeconomic development of individuals and societies.
Cataract surgical treatment leads to substantial long-term savings
in healthcare and social expenditure. Savings also accrue from
the reduced commitment made by family members caring for
a visually impaired person. Women have a significantly higher
risk of cataract blindness or being visually impaired than men,
mainly because of their higher incidence of cataract and inadequate
access to eye health care, which is often provided preferentially
to men (Lewallen 2002). The resulting downward socioeconomic
spiral can be reversed through widely available, appropriate, cost-
effective and curative surgical interventions (Kuper 2008; Polack
2008; Polack 2010).
Description of the intervention
Phacoemulsificationwas first described in 1967 byCharlesD. Kel-
man, an American ophthalmologist (1930-2004). It is the most
commonly performed method of cataract extraction in the devel-
opedworld. A small incision ismade in the cornea (with a standard
size of around 2.75 mm, but may range from 2.2 mm to 3.2 mm)
and the crystalline lens is removed by ultrasonic fragmentation
leaving the posterior lens capsule intact. This allows for a synthetic
intraocular lens (IOL) to be inserted through the corneal incision
into the capsular bag. The small incision allows rapid visual re-
habilitation postoperatively and low induced astigmatism. This
technique requires a phacoemulsification machine which may cost
GBP 20,000 to 45,000 and the costs of required disposable equip-
ment andmaintenance are also high. Phacoemulsification requires
extensive surgical training, particularly the necessity to carry out
a continuous capsulorhexis.
Extracapsular cataract extraction (ECCE) was introduced with the
development of microsurgical techniques in the early 1980s. The
lens contents are removed through a large 12 mm incision leaving
the posterior lens capsule intact. As with phacoemulsification, this
keeps the anatomical barrier between the posterior and anterior
segments of the eye intact and may reduce the risk of posterior
segment complications. A posterior chamber IOL can then be
placed in the capsular bag (Apple 1989; Duane 1986). If no IOL
is implanted, aphakic glasses or contact lenses must be used.
Extracapsular surgery has been the preferred method of extraction
in economically disadvantaged countries and most surgeons in de-
veloping countries have been trained to use this method. ECCE
may result in more induced astigmatism in the short-term com-
pared to phacoemulsification and a longer visual rehabilitation
postoperatively. Patients who have had sutured ECCE will usually
need to return to have the sutures removed in clinic, in order to
achieve the best visual acuity. Further technological development
has led to many surgeons in developing countries adopting su-
tureless ECCE surgery or manual small incision cataract surgery
(MSICS).
Both sutured and sutureless ECCE leave in place the posterior
capsule of the lens.
In the months or years after cataract surgery by either method a
small percentage of people will develop a condition called posterior
capsular thickening in which the capsule behind the new lens
becomes opacified. This can be treated using laser treatment (YAG
laser capsulotomy), in which a small opening is made in the back
of the lens capsule, which restores vision.
Figure 1 is a flow diagram summarising the different types of
cataract surgery.
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Figure 1. Types of cataract surgery
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How the intervention might work
Cataract surgery consists of removing the cloudy lens of the eye
and replacing it with an artificial lens called an intraocular lens
(IOL). Intraocular lenses can be made from a range of materials,
and they can be made of varying size, shape and refracting power.
Before cataract surgery the eye to be operated on is measured so
that an IOL of the correct power (strength) can be inserted after
the cataract has been removed. The IOL is usually placed inside
the ’bag’ of the lens capsule inside the eye. Other options for lens
replacement include contact lenses and cataract glasses.
Why it is important to do this review
Although phacoemulsification is the most technologically ad-
vanced method for providing small incision, sutureless surgery it
requires considerable resources in the form of the initial capital
outlay for the phacoemulsification machine, and there are consid-
erable ongoing costs due to consumables, maintenance and train-
ing of surgeons. It is the procedure of choice for cataract surgery
in the Western world.
From a global perspective phacoemulsification is too costly for
many developing countries where there is the highest incidence of
cataract blindness. Manual small incision surgery and ECCE are
alternative techniques available at a lower cost. A key question is
whether the resources required for phacoemulsification are justi-
fied in a lower-income setting.
This review in its original form ’Surgical interventions for age-
related cataract’ (Riaz 2006) compared the outcomes of different
cataract surgical techniques. The techniques included initiallywere
intracapsular extraction (ICCE), ECCE and phacoemulsification.
In 2006 it was revised and a fourth surgical technique (MSICS)
was added to the review.
Following consultation with the review authors and the Cochrane
Eyes and Vision Group this update has been divided into three
smaller reviews each using the same outcome measures but only
comparing two surgical methods within each review. The ICCE
technique is no longer included as this is method is no longer used
as a primary procedure.
The cataract surgical techniques compared in these three reviews
are:
1. ECCE and MSICS (Ang 2012);
2. phacoemulsification and ECCE (current review; published pro-
tocol Riaz 2010);
3. phacoemulsification and MSICS (Riaz 2013).
O B J E C T I V E S
The aim of this review is to examine the effects of two types of
cataract surgery: phacoemulsification and ECCE.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) only in this re-
view.
Types of participants
Participants in the trials were people with age-related cataract.
Types of interventions
We included trials that compared phacoemulsification with
ECCE. With both interventions a posterior chamber IOL is im-
planted.
Types of outcome measures
Primary outcomes
Postoperative visual acuity
• Proportion of people achieving good functional vision
defined as presenting* visual acuity better than or equal to 6/12
in the operated eye.
• Proportion of people with a poor outcome after surgery
defined as best corrected visual acuity (BCVA) worse than 6/60
in the operated eye.
*Presenting visual acuity is vision that the person uses in normal
life, i.e. with or without glasses, if worn.
Secondary outcomes
• Intraoperative complications
◦ capsular rupture with or without vitreous loss
◦ iris prolapse
◦ postoperative inflammation
◦ other complications as reported
• Long-term complications (one year or more after surgery)
◦ posterior capsule opacification
◦ retinal detachment
◦ glaucoma
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◦ cystoid macular oedema
◦ corneal endothelial cell loss
◦ corneal decompensation
◦ other complications as reported
• Quality of life (self care, mobility, social and mental
function) as reported
• Cost
Follow-up
Wemeasured outcomes at threemonths and one year after surgery.
As studies may not have reported outcomes exactly at these time
points we considered data collection within the following time
periods:
• three months: from four weeks to three months;
• 12 months: from six months to less than 18 months.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) 2013, Issue 4, part of The Cochrane Library.
www.thecochranelibrary.com (accessed 13 May 2013), Ovid
MEDLINE, Ovid MEDLINE In-Process and Other Non-In-
dexed Citations, Ovid MEDLINE Daily, Ovid OLDMED-
LINE (January 1946 to May 2013), EMBASE (January 1980
to May 2013), Latin American and Caribbean Health Sci-
ences (LILACS) (January 1982 to May 2013), Web of Sci-
ence Conference Proceedings Citation Index - Science (CPCI-
S) (January 1970 to May 2013), the metaRegister of Controlled
Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (
www.clinicaltrials.gov) and theWHOInternational Clinical Trials
Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We
did not use any date or language restrictions in the electronic
searches for trials. We last searched the electronic databases on 13
May 2013.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1),MEDLINE (Appendix 2), EMBASE (Appendix 3),
LILACS (Appendix 4), CPCI-S (Appendix 5), mRCT (Appendix
6), ClinicalTrials.gov (Appendix 7) and the ICTRP (Appendix 8).
Searching other resources
We searched the reference lists of identified included studies. We
contacted study authors and other experts in the field to identify
unpublished studies or studies sent for publication or in press.
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and ab-
stracts resulting from the electronic searches. We removed dupli-
cate records and obviously irrelevant titles and abstracts at this
stage. We obtained full-text copies of any report referring to def-
initely or possibly relevant trials. We linked together multiple re-
ports of the same study. We assessed these full-text reports for
compliance of studies with eligibility criteria. We assessed trials
meeting these criteria for risk of bias.
We documented all excluded studies that we obtained full-text
copies of and provided a reason for exclusion.
Data extraction and management
We extracted data using a form developed by the Cochrane Eyes
and Vision Group. Two authors extracted data and compared the
results for differences.We resolved discrepancies by discussion.We
initially addressed any disagreements which could not be resolved
by contacting the study authors, and if this was unsuccessful we
reported this in the review. Data were entered onto a spreadsheet,
checked for accuracy by all study authors, and then cut and pasted
into Review Manager (RevMan 2012).
Assessment of risk of bias in included studies
We assessed the risk of bias in each study using The Cochrane Col-
laboration’s tool for assessing the risk of bias (Higgins 2011). We
considered the following domains: sequence generation, allocation
sequence concealment, masking (blinding), incomplete outcome
data, selective outcome reporting and other potential sources of
bias. We judged each bias domain as ’high risk of bias’, ’low risk of
bias’ or ’unclear’ (indicating either lack of information or uncer-
tainty over the potential for bias). Two review authors indepen-
dently assessed the risk of bias and disagreement was resolved by
discussion. Authors were not masked to the report authors and
trial results during the assessment.
Measures of treatment effect
The outcomes for this review were largely dichotomous (postoper-
ative visual acuity and complications). Our measure of treatment
effect was the risk ratio. For outcomes that occurred rarely (in less
than 10% of the cohort), we used the Peto odds ratio. For contin-
uous outcomes, such as the percentage of corneal endothelial cell
loss, we used the mean difference.
Unit of analysis issues
The main unit of analysis issue was how the trial investigators
dealt with two eyes. There were several options here: a trial may
randomise people to the intervention groups and then apply the
intervention and/or measure the outcome in one eye (study eye)
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or both eyes. However, if the intervention had been applied to
both eyes, it would have been incorrect to analyse eyes without
taking into account the fact that the eyes for a person are not
independent. Alternatively a trial may randomly allocate eyes to
an intervention so each person had a different intervention in each
eye. In this case, the pairing would have to be taken into account
in the analysis. In the protocol for this review, if the trial had been
incorrectly analysed, we planned to contact the trial investigators
for further information to enable calculation of a design effect
(Perera 2007).
Although it was not always clearly reported, it is likely that people
were randomised to treatment and data were reported for one
(study) eye of each person in the studies included in this review.
Dealing with missing data
Our analyses are based on available data and assume that missing
data are missing at random. We collected data on follow-up by
treatment group and the reason for missingness, where available.
Assessment of heterogeneity
We assessed heterogeneity in several ways. Firstly, by documenting
clinical and methodological differences between the studies. Sec-
ondly, by examining the forest plots to see whether the estimates
of effect were consistent, and thirdly by considering the I2 statistic
value and Chi2 test for heterogeneity (bearing in mind that the
Chi2 test has low power when the number of trials is small).
Assessment of reporting biases
The main reporting biases that we considered were publication
bias and outcome reporting bias. For publication bias, we planned
to do a funnel plot to assess whether small trials had different
effects, however there were not enough trials to carry this out.
To assess outcome reporting bias we did a review outcome matrix
using the ORBIT classification (Kirkham 2010).
Data synthesis
We analysed data from studies collecting comparable outcome
measures with similar follow-up times using either the risk ratio,
Peto odds ratio or mean difference as discussed above. Where it
was appropriate to combine the results of different studies we
pooled data using a random-effects model (unless there were three
or fewer trials in which case we used a fixed-effect model).
The outcomes for this review included a number of complications.
Initially we tabulated these data only. For outcomes that were
commonly reported we went on to do a meta-analysis in order to
provide a summary estimate of risk.
Subgroup analysis and investigation of heterogeneity
One potential source of heterogeneity was the length of follow-up.
It is possible that visual outcome of surgery varies by length of fol-
low-up - in particular with respect to posterior capsule opacifica-
tion. In order to include asmany trials as possible in the analyses we
chose, a priori, a fairly broad follow-up period at 12 months (from
six months to 18 months). If trials included in this review had
very different follow-up periods, for example some at six months
and some at 18 months, we planned to group them into three
subgroups: six months, 12 months and 18 months, and allocated
trials to these groups depending on when themajority of their par-
ticipants were followed up. Currently there are not enough data
included in the review to do this analysis.
Sensitivity analysis
If there were enough trials contributing to the meta-analyses we
planned to investigate the effect of excluding poorer quality trials.
In particular, we planned to investigate the effect of excluding
trials where allocation concealment was not properly reported and
where there was no masking of outcome assessment. However,
there were not enough trials included to do this.
R E S U L T S
Description of studies
Results of the search
The electronic searches retrieved a total of 726 records (Figure 2).
After deduplication we screened 570 records. We excluded 525
records as not relevant to the scope of the review. We obtained
full-text copies of 45 records and have included 12 reports of 11
studies in the review (see Characteristics of included studies). We
have excluded 31 studies (see Characteristics of excluded studies).
Currently two studies are awaiting assessment as we are unable
to obtain a translation of the papers and have been unsuccessful
in contacting the authors to ask for assistance. If possible we will
assess them at a further update.
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Figure 2. Study flow diagram.
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Included studies
We included 11 randomised controlled trials in this review
(Chee 1999; Díaz-Valle 1998; George 2005; Kara-Junior 2010;
Katsimpris 2004; Landau 1999; Laurell 1998; MEHOX 2004;
Ravalico 1997; Rizal 2003; Stumpf 2006). See Characteristics of
included studies.
A total of 1228 people were included in these studies: 34
(Chee 1999); 60 (Díaz-Valle 1998); 112 (George 2005); 205
(Kara-Junior 2010); 94 (Katsimpris 2004); 42 (Landau 1999);
42 (Laurell 1998); 500 (MEHOX 2004); 40 (Ravalico 1997); 60
(Rizal 2003) and 39 (Stumpf 2006). The age of the participants
ranged from 45 to 94 years.
The studies were carried out in Brazil (Kara-Junior 2010; Stumpf
2006), Sweden (Landau 1999; Laurell 1998), Singapore (Chee
1999), Spain (Díaz-Valle 1998), India (George 2005), Greece (
Katsimpris 2004), theUK (MEHOX2004), Italy (Ravalico 1997)
and Malaysia (Rizal 2003).
Seven studies reported visual acuity outcomes (Chee 1999;George
2005; Katsimpris 2004; Laurell 1998; MEHOX 2004; Ravalico
1997; Stumpf 2006). However, data from four of these studies
(Katsimpris 2004; Laurell 1998; Ravalico 1997; Stumpf 2006)
were not in a suitable format for use in our analysis. Postoperative
endothelial cell loss was reported in four studies (Díaz-Valle 1998;
George 2005;Ravalico 1997; Stumpf 2006); postoperative inflam-
mation in two studies (Chee 1999; Laurell 1998); surgically in-
duced astigmatism in two studies (George 2005;MEHOX 2004);
cost of surgery in three studies (Kara-Junior 2010;MEHOX2004;
Rizal 2003) and intraocular lens (IOL) haptic position in one
study (Landau 1999).
Follow-up ranged from 30 days (Ravalico 1997) to two years (
Laurell 1998).
Excluded studies
We excluded 31 studies: see Characteristics of excluded studies for
reasons for exclusion.
Risk of bias in included studies
See Figure 3; Figure 4 and individual ’Risk of bias’ tables.
Figure 3. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 4. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Seven trials clearly stated how participants were allocated to each
arm of the study: four trials described computer-generated ran-
domisation (George 2005; Landau 1999; Laurell 1998; Rizal
2003), one study used sequentially numbered opaque envelopes
(MEHOX 2004), one study randomisation numbers (Ravalico
1997) and one study used ballots (Stumpf 2006). Four trials did
not state the method of randomisation (Chee 1999; Díaz-Valle
1998; Kara-Junior 2010; Katsimpris 2004).
Allocation concealment was only clearly described in two studies
(Laurell 1998; MEHOX 2004).
Blinding
Performance bias
Three studies reported masking of participants as to the nature
of surgery (Landau 1999; Laurell 1998; MEHOX 2004). Eight
studies did not comment.
Detection bias
Four studies reported that postoperative assessors were masked as
to the nature of surgery (George 2005; Landau 1999; Laurell 1998;
MEHOX 2004). However, obvious differences in postoperative
appearance of the eye in each groupmay have influenced the ability
to mask assessors effectively. Seven studies did not state whether
assessors were masked as to the surgical technique.
Incomplete outcome data
Follow-up rates were variable between the included studies: 83%
(Landau 1999), 88% (MEHOX 2004), 90% (George 2005),
95% (Laurell 1998), and two studies had 100% follow-up rates
(Ravalico 1997; Stumpf 2006). Five studies did not state whether
any participants were lost to follow-up or did not complete the
study period (Chee 1999; Díaz-Valle 1998; Kara-Junior 2010;
Katsimpris 2004; Rizal 2003). Three studies (Landau 1999;
Laurell 1998; MEHOX 2004) stated the reason for attrition.
Selective reporting
There were no obvious omissions in reporting results in the in-
cluded studies. Several papers did not report on visual acuity out-
comes or complications, however these were not defined outcomes
in these studies. Formal assessment of the potential for selective
outcome reporting bias using the ORBIT classification (Kirkham
2010) suggested that most non-reporting was low risk of bias
(Table 1; Appendix 9).
Other potential sources of bias
Biasmay be introduced into a study if the surgeon or surgeonswere
not equally experienced in each surgical technique and the groups
are unbalanced with respect to surgeon. Four studies stated that
surgeons were adequately experienced (George 2005; Kara-Junior
2010; Landau 1999; MEHOX 2004). The remainder of the stud-
ies did not comment on the level of surgical experience. In six stud-
ies, both surgical techniques were performed by a single surgeon
(Díaz-Valle 1998; Katsimpris 2004; Landau 1999; Laurell 1998;
Ravalico 1997; Stumpf 2006) and, with the exception of Landau
1999, it is not stated whether the surgeon had equal experience of
both techniques.
Effects of interventions
See: Summary of findings for the main comparison
Primary outcomes
The primary visual acuity outcomes for this review were present-
ing visual acuity of 6/12 or better (“good functional vision”), or a
best corrected visual acuity of worse than 6/60 (“poor visual out-
come”). None of the papers documented presenting visual acuity,
and therefore we report both uncorrected and best corrected visual
acuity. Three out of seven papers that reported visual acuity did
not state outcomes in a suitable format to include in our analysis.
Good functional vision
Uncorrected visual acuity
Chee 1999 reported UCVA of 6/12 or better at two months: this
was achieved by 15/18 participants in the phacoemulsification
group and 8/16 participants in the ECCE group (risk ratio (RR)
1.67, 95% confidence interval (CI) 0.98 to 2.84). MEHOX 2004
reportedUCVA of 6/9 or better at three months: this was achieved
by 83/237 (35%) phacoemulsification participants and 42/221
(19%) ECCE participants (RR 1.84, 95% CI 1.33 to 2.54). The
pooled risk ratio was 1.81 (95% CI 1.36 to 2.41) (Analysis 1.1).
Only one study (MEHOX 2004) reported UCVA of 6/9 or better
at the 12-month time point: this was achieved by 87/224 (39%)
participants in the phacoemulsification group and 42/215 (20%)
in the ECCE group (RR 1.99, 95% CI 1.45 to 2.73) (Analysis
1.2).
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Best corrected visual acuity
Four trials reported best corrected visual acuity of 6/12 or better
at three months (Analysis 1.3) and one study at 12 months (
Analysis 1.4). At three months there was a small benefit in favour
of phacoemulsification (pooled RR 1.12, 95% CI 1.03 to 1.22).
At 12 months the effect was smaller and uncertain (pooled RR
1.06, 95% CI 0.99 to 1.14).
Poor visual outcome
Poor visual acuity was reported in two trials with a lower inci-
dence of poor BCVA in the phacoemulsification group (RR 0.33,
95% CI 0.20 to 0.55) (Analysis 1.5). In the George 2005 study
a visual acuity of worse than 6/18 at six weeks was reported in 0/
60 phacoemulsification participants and 5/52 ECCE participants
(RR 0.08, 95% CI 0.0 to 1.4). In the MEHOX 2004 study, visual
acuity worse than 6/9 was reported at three months in 17/237
phacoemulsification participants and 44/221 ECCE participants
(RR 0.36, (95% CI 0.21 to 0.61).
At 12 months, BCVA worse than 6/9 was reported by MEHOX
2004 in 20/244 phacoemulsification participants and 31/215
ECCE participants (RR 0.62, 95% CI 0.36 to 1.05) (Analysis
1.6).
Additional visual outcome data
These studies included visual acuity data that were not in a suitable
format for inclusion in our analysis.
Ravalico 1997 reported mean corrected decimal visual acuity at
30 days after surgery in the phacoemulsification group of 0.95
+/- 0.11 and the ECCE group of 0.92 +/- 0.10 (P value non-
significant).
Stumpf 2006 reported an average corrected visual acuity at one,
three and six months postoperatively. At the one and three-month
time points, mean BCVA was better in the phacoemulsification
group. The average decimal visual acuity was 0.83 in the pha-
coemulsification group and 0.68 in the ECCE group (P = 0.02)
at one month and it was 0.86 in the phacoemulsification group
versus 0.77 in the ECCE group (P = 0.04) at three months. How-
ever, at six months there was no significant difference between the
two groups (0.87 in the phacoemulsification group, 0.81 in the
ECCE group, P = 0.35).
Katsimpris 2004 reported BCVA as mean logMAR at 14 months
and found a better average BCVA in the phacoemulsification
group (0.3 logMAR units) compared to the ECCE group (0.5
logMAR units).
Secondary outcomes
Intraoperative complications
Posterior capsular rupture was reported in three studies (George
2005; Katsimpris 2004;MEHOX 2004) (Analysis 1.7). The over-
all ratewas lower in the phacoemulsification group: 10/353 (2.8%)
versus 17/335 (5.1%) in the ECCE group (Peto odds ratio (OR)
0.56, 95%CI 0.26 to 1.22). In most papers only a few events were
reported, with the exception of Katsimpris 2004, however this is
likely to reflect the nature of pseudoexfoliative cataracts in this
study, which are recognised to have a higher surgical complication
rate.
Iris prolapse was reported in only the MEHOX 2004 study, with
a rate of 0/246 cases in the phacoemulsification group and 17/236
cases in the ECCE group (Peto OR 0.12, 95% CI 0.05 to 0.32).
Other intraoperative complications are tabulated here: Analysis
1.9.
Postoperative complications
Posterior capsule opacification was reported in two studies (
Katsimpris 2004; MEHOX 2004) (Analysis 1.10) at 12 to 14
months with an overall rate of 17/292 (5.8%) in the phacoemul-
sification group and 40/279 (14.3%) in the ECCE group (Peto
OR 0.38, 95% CI 0.22 to 0.66).
Retinal detachment was reported by MEHOX 2004 in 2/245
phacoemulsification cases and 0/232 ECCE cases (Peto OR 7.04,
95% CI 0.44 to 112.93) (Analysis 1.11).
Cystoid macular oedema was reported in two studies (Katsimpris
2004; MEHOX 2004) with an overall rate of 3/292 in the pha-
coemulsification group and 11/279 in the ECCE group (Peto OR
0.29, 95% CI 0.10 to 0.86) (Analysis 1.12).
Corneal endothelial cell loss was reported in four studies, however
the data from Ravalico 1997 were not included in our analysis,
since it could not be compared to other studies. Overall there was
no significant difference between the two techniques in terms of
percentage of endothelial cell loss (mean difference 1.00, 95% CI
-0.88 to 2.89) (Table 2; Analysis 1.8).
Endophthalmitis rates were reported in only the MEHOX 2004
study with rates of 3/245 (1%) in the phacoemulsification group
and 1/232 (0.4%) in the ECCE group.
Other complications are tabulated here: Analysis 1.14.
Quality of life
None of the studies reported quality of life.
Cost
Three studies reported the cost of cataract surgery in Brazil (Kara-
Junior 2010), theUK (MEHOX2004) andMalaysia (Rizal 2003).
• Kara-Junior 2010 reported a cost of surgery of USD 242.23
for phacoemulsification and USD 155.50 for ECCE.
• MEHOX 2004 reported a cost of GBP 359.89 for
phacoemulsification and GBP 367.57 for ECCE. Costs for
phacoemulsification and ECCE were similar up to six weeks
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postoperatively, but following this time point ECCE incurred
additional costs due to additional visits, spectacles and laser
treatment to achieve a similar outcome.
• Rizal 2003 reported a cost of MYR 1978 for
phacoemulsification and MYR 1664.46 for ECCE.
D I S C U S S I O N
Summary of main results
The results are summarised in Summary of findings for the main
comparison.
Our primary defined outcome was presenting visual acuity of 6/12
or better, and since no study reported this directly we report both
uncorrected and best corrected visual acuity. Only four studies re-
ported this outcome: at both the three-month and 12-month time
point phacoemulsification gave superior results to ECCE both in
terms of uncorrected and best corrected visual acuity, although for
best corrected acuity the size of the effect was small.
We defined poor visual outcome as BCVA of less than 6/60: the
three papers that included poor BCVA data reported worse than
6/9 and 6/18. The number of events in each group was small,
making it difficult to draw conclusions. However, there were fewer
events in the phacoemulsification group than the ECCE group at
both the three-month (risk ratio 0.33, 95% CI 0.20 to 0.55) and
12-month time points (risk ratio 0.62, 95% CI 0.36 to 1.05).
Regarding complication rates, the three papers stated posterior
capsule rupture rates (PCR). This was higher in the ECCE group
than the phacoemulsification group, however these results may
be skewed by the high complication rate in the Katsimpris 2004
paper which only included complicated cataracts in participants
with pseudoexfoliation. If this paper is excluded from analysis, the
PCR rates for the two techniques are approximately equal.
The rates of iris prolapse, cystoid macular oedema and posterior
capsular opacification were also higher in the ECCE group than
the phacoemulsification group. Regarding other complications,
the event rate was too low to draw definite conclusions regarding
the superiority of one technique over another.
Phacoemulsification surgical costs were higher than ECCE in two
studies (Kara-Junior 2010; Rizal 2003). MEHOX 2004 reported
similar costs for phacoemulsification and ECCE up to six weeks
postoperatively, but following this time point ECCE incurred ad-
ditional costs due to additional visits, spectacles and laser treat-
ment to achieve a similar outcome. Therefore the overall cost of
phacoemulsification was slightly lower than ECCE in this study.
Overall completeness and applicability of
evidence
Collation of evidence from all studies was difficult, due to vary-
ing methods of outcome reporting. For example visual acuity was
documented in seven studies as Snellen, mean logMAR and mean
decimal visual acuity, which weremeasured at varying time points.
There were relatively small numbers of events across all studies
regarding complications and therefore it is difficult to draw overall
conclusions. The severity of cataract varied across studies, with
some studies only including hard or pseudoexfoliative cataracts,
and others excluding thesemore complicated cataracts. Thismakes
it difficult to apply the results regarding complication rates to all
levels of difficulty of cataract surgery.
The 11 included studies were carried out in nine countries, ranging
from teaching hospitals in developed countries to high-volume
cataract centres in developing countries. Therefore the results from
this review may be applicable to multiple settings.
Quality of the evidence
All studies included in this review were randomised controlled tri-
als. The quality of evidence, however, was low or very low, and this
was due to inconsistency of reporting outcome data. Due to the
slow postoperative recovery of visual acuity with ECCE surgery,
long-term visual outcome data are especially important when com-
paring phacoemulsification to ECCE. Comparing visual outcome
data between these two techniques at a time point earlier than
three months may therefore have limited value. Despite four stud-
ies having a follow-up period of 12 months or longer, there were
few data on long-term visual outcomes and complications such as
posterior capsule opacification in these studies.
Potential biases in the review process
No obvious biases were identified in the review process.
Agreements and disagreements with other
studies or reviews
A study carried out in Pakistan found 80% of phacoemulsifica-
tion and 54% of ECCE participants had a postoperative unaided
visual acuity of 6/12 or better three months after surgery, and this
trend is consistent with our results (Nangrejo 2011). A recent ret-
rospective review of complications arising from 20,438 cases of
phacoemulsification and 5736 cases of ECCE found a complica-
tion rate of 1.11% in the phacoemulsification group and 2.6% in
the ECCE group. There were no statistically significant differences
in the rate of endophthalmitis between the surgical techniques
(Haripriya 2012). These findings are consistent with those of this
review.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There was some evidence from one study that uncorrected visual
acuity outcomes were better in the phacoemulsification group 12
months after surgery. Only four studies were incorporated into
our analysis of visual acuity at up to 3 or 12 months, but data
in three other included papers (which were not included in the
analysis due to the method of recording visual acuity) supported
these findings. Regarding complications, the numbers of events
were small, however there appears to be a higher rate of posterior
capsule rupture and also posterior capsule opacification in the
ECCE group compared to the phacoemulsification group. It is
difficult to determine a difference regarding other complications
due to the low numbers involved.
Overall, phacoemulsification appears to give better visual out-
comes and fewer complications than ECCE. The lower cost of
ECCE in two out of three studies may favour ECCE where re-
sources are limited. However, a greater number of outpatient post-
operative visits associated with the ECCE group may indirectly
increase the costs of this technique, as shown in the MEHOX
2004 study.
Implications for research
Future studies need to have standardised reporting of outcomes
enabling data from different studies to be pooled, in particular a
precise and reproducible method of reporting visual acuity. In the
absence of a formal core outcome set for such trials, we suggest that
the primary outcomes we have included in this review (presenting
Snellen visual acuity 6/12 or better and best corrected visual acuity
worse than 6/60) should be reported as a minimum. Future trials
should also collect information on vision-related quality of life
and cost utility. It should also be clearly stated whether one eye
was operated on per participant or both eyes, and whether this
decision was made prior to observing the outcome, as this may
introduce bias.
Most of the trials included in this review had a relatively short
follow-up period. We recommend a longer follow-up period, ide-
ally 12 months or more. We recognise that this may be difficult
in some populations but it is important especially with regard to
complications such as posterior capsule opacification which may
become visually significant over a longer time course.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chee 1999
Methods Parallel-group randomised controlled trial
Number randomised: 34 participants
Unclear but likely that people were randomly allocated and 1 eye per person operated
Length of follow-up 90 days
Participants Country: Singapore
Inclusion criteria: age-related cataract
Exclusion criteria: diabetics
Age, years: mean 63.1
Gender: 15 men, 19 women
Ethnicity: Chinese and Malay
Interventions Phacoemulsification (18 eyes) versus ECCE (16 eyes)
Outcomes Postoperative inflammation measured at post-operative day 4, 8, 15, 30, 60, 90 with
laser flare meter/slit lamp
Snellen VA at 2 months
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients having cataract surgery were ran-
domized to ECCE or phacoemulsification.
” Page 1281
Details of randomisation procedure not
stated
Allocation concealment (selection bias) Unclear risk Details not stated
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “Also, to reduce bias, two surgeons per-
formed both types of surgery” Page 1281
Not stated if participant masked to type of
surgery
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “1 independent postoperative observer (M.
S.) was masked as to surgical procedure”
Page 1281 (suture techniques different)
Incomplete outcome data (attrition bias)
All outcomes
Low risk There is no indication in the paper that
any participants did not complete the full
follow-up period
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Chee 1999 (Continued)
Selective reporting (reporting bias) Low risk None obvious
Díaz-Valle 1998
Methods Parallel-group randomised controlled trial
Total number of participants: 60
1 eye per person included in the trial; unclear how the eye was selected for surgery
Length of follow-up: 3 months
Participants Country: Spain
Inclusion criteria: age-related cataract
Exclusion criteria: other ocular pathologies, high refractive defects, glaucoma, diabetes
mellitus, and intraoperative or postoperative complications
Age, years: mean 70.5 years +/- 7.6 (range 58 to 79 years)
Gender: 27 men, 33 women
Interventions Group1: phacoemulsification (20 eyes)
Group 2: ECCE with planned continuous curvilinear capsulorhexis (20 eyes)
Group3: ECCE with letterbox capsulotomy (20 eyes)
Outcomes Endothelial permeability
Endothelial cell loss
Pachymetry
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details stated in paper
Allocation concealment (selection bias) Unclear risk No details stated in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “All surgerywas performedby the same sur-
geon.” Page 952
No details regarding masking of surgeon,
participants or other staff given
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed in paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk There is no indication in the paper that
any participants did not complete the full
follow-up period
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Díaz-Valle 1998 (Continued)
Selective reporting (reporting bias) Unclear risk No details of intraoperative complications
recorded in paper
George 2005
Methods Parallel-group randomised controlled trial
Number randomised: 186 participants
Unclear but likely that people were randomly allocated and 1 eye per person operated
Follow-up: 3 to 4 weeks (phaco), 8 weeks (ECCE)
Participants Country: India
Inclusion criteria: participant undergoing planned cataract surgery; otherwise normal
preoperative examination; cataract < grade III
Exclusion criteria: other potential causes of decreased vision; complicated cataracts; non
age-related cataracts; phacodonesis; glaucoma or retinal pathology
Age, years: phacoemulsification: 59.63 (SD 7.64) years, ECCE 57.85 (SD 8.01) years
Gender: phacoemulsification 27 men, 33 women, ECCE 23 men, 29 women
Interventions Phacoemulsification (62 eyes) versus ECCE (62 eyes) versus MSICS (62 eyes)
Outcomes Surgically induced astigmatism
Endothelial cell loss
Snellen visual acuity
Notes Published data only. No correspondence with authors
Phacoemulsification - 5 mm incision rigid lens
ECCE - can-opener capsulotomy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Cases were randomized into three groups
based on computer-generated random
numbers. Randomization was carried out
at the time of admission and used the hos-
pital numbers (which were allotted at the
time of the first hospital visit) for allocation
into different groups”. Page 294
Allocation concealment (selection bias) Unclear risk Not detailed in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study does not document whether partici-
pants or personnel were aware/informed of
which intervention they were assigned to
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George 2005 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Independent observers performed refrac-
tion and keratometry in order to minimize
bias”. Page 295
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The 6-week follow-up was completed by
52/62 cases of ECCE, 53/62 cases of
MSICS and 60/62 cases of phacoemulsifi-
cation
The reasons for attrition were not stated
Selective reporting (reporting bias) Low risk None obvious
Kara-Junior 2010
Methods Parallel-group randomised controlled trial
Number randomised: 205 participants
Each person only had 1 eye operated; it was not clear how the eye was selected
Follow-up: 8 weeks
Participants Country: Brazil
Inclusion criteria: age 41 to 80 years, senile cataract, BCVAworse than 20/40 or logMAR
0.3 in better eye, participant living less than 100 km from hospital
Exclusion criteria: presence of any physical or clinical restrictions besides visual problem,
presence of any ocular disease that could contribute to decreased visual acuity, previous
ocular surgery, amblyopia
Age, years: phacoemulsification: mean 68.3 (SD 9) years, ECCE 69.1 (SD 8.5) years
Gender: phacoemulsification: 35.3% men, ECCE 44.1% men
Interventions Phacoemulsification (101 eyes) versus ECCE (104 eyes)
Outcomes Governmental cost of participants undergoing phacoemulsification and ECCE
Benefits after cataract surgery in productivity at work and motivation to seek work
Social costs (for employers, participants, care givers and social security)
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The selected patients were randomly as-
signed to two groups” Page 2
Details of themethod of randomisation are
not stated
Allocation concealment (selection bias) Unclear risk Not detailed in paper
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Kara-Junior 2010 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not detailed in paper
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed in paper
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 17 participants in phacoemulsifica-
tion group and 14 participants in ECCE
group were employed, and the estimated
social security costs per participant were
based on these sample sizes only. (The re-
maining participants were retired, home-
makers, seeking employment or not look-
ing for a job)
Selective reporting (reporting bias) Unclear risk None related to defined outcomes (cost of
surgery)
Katsimpris 2004
Methods Randomised controlled trial
Number randomised: 94 participants
Each person only had 1 eye operated; it was not clear how the eye was selected
Follow-up: mean 14 ± 6.2 months
Participants Country: Greece
Inclusion criteria: particpants with cataract in association with pseudoexfoliation; small
pupil; small to moderate phacodonesis
Exclusion criteria: partial or complete subluxation; vitreous present in anterior chamber
Age, years: phacoemulsification: 77 (SD 5.3) years, ECCE 75.5 (SD 6.0)
Interventions Phacoemulsification (47 eyes) versus ECCE (47 eyes)
Outcomes Intraoperative zonular tears
Capsular rupture
Vitreous loss
Corneal oedema
LogMAR visual acuity
Posterior capsule opacification
Intraocular pressure spikes
IOL decentration
Notes Published data only. No correspondence with authors
Risk of bias
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Katsimpris 2004 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not detailed in paper
Allocation concealment (selection bias) Unclear risk Not detailed in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not detailed in paper
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed in paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk No details of any participant not complet-
ing follow-up
Selective reporting (reporting bias) Low risk None obvious
Landau 1999
Methods Parallel-group randomised controlled trial
Number randomised: 42 participants (21 to phacoemulsification, 21 to ECCE)
Each person only had 1 eye operated; it was not clear how the eye was selected
Follow-up: 1.5 to 2.5 years
Participants Country: Sweden
Inclusion criteria: participants with cataract
Exclusion criteria: no other ocular disease
Age, years: mean (range) 74.25 (68 to 82) years
Gender: 11 men, 24 women (35 participants followed up)
Interventions 35 participants followed up
Phacoemulsification (17 eyes) versus ECCE (18 eyes)
Outcomes Ultrasound biomicroscopy examination of IOL haptic position
Anterior chamber depth
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “At the preoperative examination the pa-
tients were randomly assigned to Group I
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Landau 1999 (Continued)
or Group II by a computer generated ran-
domisation schedule”. Page 394
Allocation concealment (selection bias) Unclear risk Not stated in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “The patients were unaware of the surgical
technique used”. Page 394
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All UBM examinations were performed
by one of the authors who was unaware
of the surgical technique used for cataract
extraction”. Page 395
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Two patients died before the start of the
UBM study and five declined to be exam-
ined by UBM”. Page 395
Selective reporting (reporting bias) Low risk None obvious
Laurell 1998
Methods Randomised controlled trial
Number randomised: 42 participants
Follow-up: 2 years
Participants Country: Sweden
Inclusion criteria: participants enrolled for cataract surgery; age 64 to 82 years
Exclusion criteria: pseudoexfoliation syndrome; small pupils (< 5 mm post dilatation);
glaucoma; uveitis; dark brown irides; diabetes; treatment with eye drops or anti-inflam-
matory drugs
Age, years: phacoemulsification: median 73 years, range 65 to 82, ECCE: range 64 to
79
Gender: phacoemulsification 62% women, ECCE 67% women
Interventions Phacoemulsification (21 eyes) versus ECCE (21 eyes)
Outcomes Operation time
Blood-aqueous barrier reaction (3 months)
Laser flare meter in anterior chamber (2 years)
Snellen visual acuity (3 months)
Corneal thickness (at 3 months)
Notes Envelope capsulotomy for ECCE
Published data only. No correspondence with authors
Risk of bias
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Laurell 1998 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomly assigned to phacoemulsification
(group I) or ECCE (group II) by a com-
puter generated randomisation schedule
thus the allocation was not dependent on
characteristics of the eye” Page 574
Allocation concealment (selection bias) Low risk “The patients were not informed about the
surgical method”. Page 574
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated in paper
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “the analyst was not aware of the surgical
method at the time of calculation of diffu-
sion coefficients”. Page 575
Incomplete outcome data (attrition bias)
All outcomes
High risk Not all visual acuity data reported for all
participants
“One patient in group II died between
the three months and one year examina-
tions. In group I the BABmeasurements of
one participant were discarded because fine
pseudoexfoliations were found after the pa-
tient had entered the study. the other drop-
outs were due to patients unavailable for
follow up”. Page 575
Selective reporting (reporting bias) Unclear risk No details of intraoperative complications
recorded in paper
MEHOX 2004
Methods Randomised controlled trial (2 centres)
Number randomised: 500 participants (251 participants randomised to phacoemulsifi-
cation, 249 to ECCE)
Each person only had 1 eye operated, “The choice of eye in those with bilateral cataracts
was as in routine clinical practice, and was independent of the allocated surgical treatment-
that is, was made before randomisation.”
Length of follow-up: 1 year
Participants Country: UK
Inclusion criteria: consenting participant; age-related cataract; resident in the region;
willing and able to attend regular follow-up
Exclusion criteria: hard, highly brunescent cataracts; eye disorders that may compromise
vision (e.g. amblyopia, glaucoma, diabetic retinopathy, macular degeneration); high my-
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MEHOX 2004 (Continued)
opes (axial length > 26.5 mm)
Age, years: mean 72, range 40+ years
Gender: (of people with complete data): phacoemulsification 91 men, 132 women,
ECCE 97 men, 113 women
Interventions Phacoemulsification (244 participants received the allocated treatment) versus ECCE
(232 participants)
Outcomes 439 participants completed trial, 433 participants had complete data
Snellen visual acuity
Astigmatism
Capsule rupture/vitreous loss
Capsule opacity at 1 year
Endothelial cell loss
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The unit of randomisation was the indi-
vidual patient, with only one eye consid-
ered for cataract surgery. The randomisa-
tion was stratified by surgeon with blocks
of size four and six”. Page 825
Allocation concealment (selection bias) Low risk “The allocation codes were sealed in se-
quentially numbered opaque envelopes,
and placed in the care of the trial man-
ager in each study centre. The participating
surgeons were not involved in the care of
or opening of the envelopes, and were in-
formed of the treatment assignment in the-
atre immediately before surgery. The trial
statistician who generated the allocation
schedules was not involved in execution of
the assignment”. Page 825
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “As in many surgical trials, complete mask-
ing was not possible. The patients and the
optometrists in charge of the followup out-
come assessments were masked to the treat-
ment allocation code“. Page 825
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ”optometrists in charge of the follow
up outcome assessments were masked to
the treatment allocation code. The op-
tometrists examining the patient, however,
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MEHOX 2004 (Continued)
could not be masked to the size and loca-
tion of the surgical incision, which indi-
cated the type of surgery”. Page 825
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “similar numbers were lost in the two treat-
ment groups, and the reasons for loss-
mainly problems with attendance due to
change of residence or death-were similar
in the two groups”. Page 828
Selective reporting (reporting bias) Low risk None obvious
Ravalico 1997
Methods Parallel-group randomised controlled trial
Number randomised: 40 participants
People were randomly allocated to treatment and likely (but not clearly stated) that 1
eye per person operated
Follow-up: mean 30 days
Participants Country: Italy
Inclusion criteria: participants scheduled for cataract surgery
Exclusion criteria: high refractive defects (> 4.0 dioptres); other ocular pathologies; dia-
betes mellitus; intraoperative or postoperative complications
Age, years: phacoemulsification mean 62.9 (SD 6.2) (range 60 to 70), ECCE: mean 63.
7 (SD 6.7) years
Interventions Phacoemulsification (20 eyes) versus ECCE (20 eyes)
Outcomes Mean endothelial cell density
Coefficient of variation in cell size
Pachymetry
Endothelial cell pump function and permeability coefficient
Mean decimal visual acuity
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Forty patients scheduled for cataract
surgery were divided by randomization
numbers into two groups of 20 patients
each”. Page 1001
Allocation concealment (selection bias) Unclear risk No details stated in paper
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Ravalico 1997 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “All ECCE and phacoemulsification proce-
dures were performed by the same surgeon.
” Page 1001
No details regarding masking of partici-
pants or other staff given
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details stated in paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk “No patient dropped out of the study”.
Page 1001
Selective reporting (reporting bias) Unclear risk No details of intraoperative complications
recorded in paper
Rizal 2003
Methods Parallel-group randomised controlled trial
Number randomised: 60 participants
Unclear but likely that people were randomly allocated and 1 eye per person operated
Follow-up: 2 months
Participants Country: Malaysia
Inclusion criteria: age over 40, BCVA of 6/60 or better with symptoms of cataract
Exclusion criteria: senile dementia, frailty or deformity, have a past history of eye injury,
undergoing any major surgery within the study period, anxious participants who require
general anaesthesia, participants with cerebral vascular accident causing significant visual
loss. Participants with glaucoma, maculopathy, difficult pupillary dilation, media opacity
such as vitreous haemorrhage and any central corneal opacity of 3 mm diameter
Age, years: range 45 to 94 years
Gender: phacoemulsification 12 men, 18 women, ECCE 12 men, 18 women
Ethnicity: Malay, Chinese, Indian
Interventions Phacoemulsification (30 eyes) versus ECCE (30 eyes)
Outcomes Cataract surgery cost
Notes Published data only. No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Using a computer generated randomisa-
tion table, they were subjected to either
ECCE or PEA”. Page 381
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Rizal 2003 (Continued)
Allocation concealment (selection bias) Unclear risk Not detailed in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not detailed in paper
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed in paper
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not detailed in paper
Selective reporting (reporting bias) Unclear risk No details of intraoperative complications
recorded in paper
Stumpf 2006
Methods Randomised controlled trial
Number randomised: 41 eyes in 39 participants
Follow-up: 180 days
Participants Country: Brazil
Inclusion criteria: senile cataract with hard cataract, possibility of return examinations
for at least 6 months
Exclusion criteria: presence of ocular pathology, prior eye surgery in the eye studied,
diabetes mellitus, participants who were unable to do 6 months postoperative follow-up
Age, years: 54 to 88
Gender: 12 men, 27 women
Interventions Phacoemulsification (20 eyes) versus ECCE (21 eyes)
Outcomes Decimal VA at 1, 3 and 6 months
Endothelial cell loss
Pachymetry
Notes Published data only (paper translated from Portuguese original). No correspondence
with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomised using a bal-
lot system. “The patients were randomly
divided by lot into two groups”. Page 492
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Stumpf 2006 (Continued)
Allocation concealment (selection bias) Unclear risk Not detailed in paper
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not detailed in paper
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not detailed in paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed 6-month fol-
low-up period
Selective reporting (reporting bias) Unclear risk No details of intraoperative complications
recorded in paper
BCVA: best corrected visual acuity
ECCE: extracapsular cataract extraction
IOL: intraocular lens
MSICS: manual small incision cataract surgery
SD: standard deviation
UBM: ultrasound biomicroscopy
VA: visual acuity
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arriaga 2002 Not a RCT
Balent 2001 Not strictly a RCT. “Patients were randomly assigned to any surgeon’s table as soon as the table emptied”
Bellucci 1995 Study in people with small pupils
Bovet 1992 Not a RCT
Bovet 1994 Not a RCT
Bömer 1995 Surgical technique was not randomly allocated
Cavallini 1996 Not a RCT
Dam-Johansen 1993 Not a RCT
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(Continued)
Dowler 2000 Participants were diabetic therefore may not have had age-related cataract
Egger 1994 Not a RCT
Geerling 2000 Not a RCT
Grinbaum 2003 Not a RCT
Honda 1995 Not a RCT
Kim 1996 Study of intraocular pressure change only
Lagreze 1996 Participants only randomly allocated to phacoemulsification, not to ECCE
Li 2005 Not a RCT
Liu 1995 Not a RCT
Liu 2003a Not a RCT
Liu 2003b Not a RCT
Loo 2004 Not a RCT
Lupidi 1994 Not a RCT
Ma 2000 Not a RCT
Matheu 1997 Does not compare phacoemulsification and ECCE
Moulick 2009 Not a RCT
Muralikrishnan 2004 Not a RCT
Müller-Jensen 1996 Not a RCT
Okinami 1994 Not a RCT
Ram 2001 Not a RCT
Sun 2010 Not a RCT
Watson 1992 Not a RCT
Yasuyoshi 1995 Not a RCT
ECCE: extracapsular cataract extraction
RCT: randomised controlled trial
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Characteristics of studies awaiting assessment [ordered by study ID]
Durovic 2004
Methods
Participants
Interventions
Outcomes
Notes Awaiting translation
Trnavec 1997
Methods
Participants
Interventions
Outcomes
Notes Awaiting translation
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D A T A A N D A N A L Y S E S
Comparison 1. Phacoemulsification versus ECCE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Good functional vision at 3
months (uncorrected acuity)
2 492 Risk Ratio (M-H, Fixed, 95% CI) 1.81 [1.36, 2.41]
2 Good functional vision at 12
months (uncorrected acuity)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Good functional vision at 3
months (best corrected acuity)
4 645 Risk Ratio (M-H, Random, 95% CI) 1.12 [1.03, 1.22]
4 Good functional vision at 12
months (best corrected acuity)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Poor visual outcome at 3 months
(best corrected acuity 6/60 or
worse)
3 604 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.20, 0.55]
6 Poor visual outcome at 12
months (best corrected acuity
6/60 or worse)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7 Capsular rupture 3 688 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.56 [0.26, 1.22]
8 % corneal endothelial cell loss 3 605 Mean Difference (IV, Fixed, 95% CI) 1.00 [-0.88, 2.89]
9 Other intraoperative
complications
Other data No numeric data
10 Posterior capsule opacification 2 571 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.38 [0.22, 0.66]
11 Retinal detachment 1 Peto Odds Ratio (Peto, Fixed, 95% CI) Totals not selected
12 Cystoid macular oedema 2 571 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.29 [0.10, 0.86]
13 Iris prolapse 1 Peto Odds Ratio (Peto, Fixed, 95% CI) Totals not selected
14 Other complications Other data No numeric data
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Analysis 1.1. Comparison 1 Phacoemulsification versus ECCE, Outcome 1 Good functional vision at 3
months (uncorrected acuity).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 1 Good functional vision at 3 months (uncorrected acuity)
Study or subgroup Phacoemulsification ECCE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chee 1999 (1) 15/18 8/16 16.3 % 1.67 [ 0.98, 2.84 ]
MEHOX 2004 (2) 83/237 42/221 83.7 % 1.84 [ 1.33, 2.54 ]
Total (95% CI) 255 237 100.0 % 1.81 [ 1.36, 2.41 ]
Total events: 98 (Phacoemulsification), 50 (ECCE)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 4.10 (P = 0.000041)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ECCE Favours phaco
(1) 6/12 or better, 2 months follow-up
(2) 6/9 or better, 3 months follow-up
Analysis 1.2. Comparison 1 Phacoemulsification versus ECCE, Outcome 2 Good functional vision at 12
months (uncorrected acuity).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 2 Good functional vision at 12 months (uncorrected acuity)
Study or subgroup Phacoemulsification ECCE Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MEHOX 2004 (1) 87/224 42/215 1.99 [ 1.45, 2.73 ]
0.01 0.1 1 10 100
Favours ECCE Favours phaco
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(1) 6/9 or better
Analysis 1.3. Comparison 1 Phacoemulsification versus ECCE, Outcome 3 Good functional vision at 3
months (best corrected acuity).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 3 Good functional vision at 3 months (best corrected acuity)
Study or subgroup Phacoemulsification ECCE Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chee 1999 (1) 17/18 15/16 18.9 % 1.01 [ 0.85, 1.19 ]
George 2005 (2) 60/60 47/52 36.0 % 1.11 [ 1.01, 1.22 ]
Laurell 1998 (3) 16/21 9/20 2.6 % 1.69 [ 0.99, 2.91 ]
MEHOX 2004 (4) 220/237 177/221 42.6 % 1.16 [ 1.08, 1.25 ]
Total (95% CI) 336 309 100.0 % 1.12 [ 1.03, 1.22 ]
Total events: 313 (Phacoemulsification), 248 (ECCE)
Heterogeneity: Tau2 = 0.00; Chi2 = 5.42, df = 3 (P = 0.14); I2 =45%
Test for overall effect: Z = 2.54 (P = 0.011)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ECCE Favours phaco
(1) 6/12 or better, 2 months follow-up
(2) 6/12 or better, 6 weeks follow-up
(3) better than 6/6, 3 months follow-up
(4) 6/9 or better, 3 months follow-up
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Analysis 1.4. Comparison 1 Phacoemulsification versus ECCE, Outcome 4 Good functional vision at 12
months (best corrected acuity).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 4 Good functional vision at 12 months (best corrected acuity)
Study or subgroup Phacoemulsification ECCE Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MEHOX 2004 (1) 204/224 184/215 1.06 [ 0.99, 1.14 ]
0.01 0.1 1 10 100
Favours ECCE Favours phaco
(1) 6/9 or better
Analysis 1.5. Comparison 1 Phacoemulsification versus ECCE, Outcome 5 Poor visual outcome at 3
months (best corrected acuity 6/60 or worse).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 5 Poor visual outcome at 3 months (best corrected acuity 6/60 or worse)
Study or subgroup Phacoemulsification ECCE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chee 1999 (1) 0/18 0/16 Not estimable
George 2005 (2) 0/60 5/52 11.4 % 0.08 [ 0.00, 1.40 ]
MEHOX 2004 (3) 17/237 44/221 88.6 % 0.36 [ 0.21, 0.61 ]
Total (95% CI) 315 289 100.0 % 0.33 [ 0.20, 0.55 ]
Total events: 17 (Phacoemulsification), 49 (ECCE)
Heterogeneity: Chi2 = 1.07, df = 1 (P = 0.30); I2 =6%
Test for overall effect: Z = 4.23 (P = 0.000024)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours phaco Favours ECCE
39Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber
intraocular lens for age-related cataract (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(1) worse than 6/12, 2 months follow-up
(2) 6/18 or worse, 6 weeks follow-up
(3) worse than 6/9, 3 months follow-up
Analysis 1.6. Comparison 1 Phacoemulsification versus ECCE, Outcome 6 Poor visual outcome at 12
months (best corrected acuity 6/60 or worse).
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 6 Poor visual outcome at 12 months (best corrected acuity 6/60 or worse)
Study or subgroup Phacoemulsification ECCE Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
MEHOX 2004 (1) 20/224 31/215 0.62 [ 0.36, 1.05 ]
0.01 0.1 1 10 100
Favours phaco Favours ECCE
(1) worse than 6/9
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Analysis 1.7. Comparison 1 Phacoemulsification versus ECCE, Outcome 7 Capsular rupture.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 7 Capsular rupture
Study or subgroup Phacoemulsification ECCE
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
George 2005 0/60 0/52 Not estimable
Katsimpris 2004 2/47 8/47 35.5 % 0.26 [ 0.07, 0.98 ]
MEHOX 2004 8/246 9/236 64.5 % 0.85 [ 0.32, 2.23 ]
Total (95% CI) 353 335 100.0 % 0.56 [ 0.26, 1.22 ]
Total events: 10 (Phacoemulsification), 17 (ECCE)
Heterogeneity: Chi2 = 1.97, df = 1 (P = 0.16); I2 =49%
Test for overall effect: Z = 1.46 (P = 0.15)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours phaco Favours ECCE
41Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber
intraocular lens for age-related cataract (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.8. Comparison 1 Phacoemulsification versus ECCE, Outcome 8 % corneal endothelial cell loss.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 8 % corneal endothelial cell loss
Study or subgroup Phacoemulsification ECCE
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
D az-Valle 1998 20 11.8 (6.7) 40 11.45 (7.38) 25.8 % 0.35 [ -3.37, 4.07 ]
George 2005 60 5.41 (10.99) 52 4.72 (13.07) 17.5 % 0.69 [ -3.82, 5.20 ]
MEHOX 2004 223 10.5 (11.95) 210 9.1 (14.49) 56.7 % 1.40 [ -1.11, 3.91 ]
Total (95% CI) 303 302 100.0 % 1.00 [ -0.88, 2.89 ]
Heterogeneity: Chi2 = 0.23, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours phaco Favours ECCE
Analysis 1.9. Comparison 1 Phacoemulsification versus ECCE, Outcome 9 Other intraoperative
complications.
Other intraoperative complications
Study Complication Result
Katsimpris 2004 Vitreous loss Phacoemulsification: 2/47 (4%), ECCE: 8/47 (17%)
Landau 1999 IOL haptic located in capsular bag Phacoemulsification: 18/18 (100%), ECCE: 10/17
(59%)
MEHOX 2004 Choroidal haemorrhage
Iris torn or emulsified
Other “minor” difficulties including:
- anterior chamber collapse or bleed
- anterior capsule tear
- incomplete capsulorhexis
Phacoemulsification: 1/246 (0.4%), ECCE: 1/236 (0.
4%)
Phacoemulsification: 2/246 (1%), ECCE: 5/236 (2%)
Phacoemulsification: 6/246 (2%), ECCE: 16/236 (7%)
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Analysis 1.10. Comparison 1 Phacoemulsification versus ECCE, Outcome 10 Posterior capsule
opacification.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 10 Posterior capsule opacification
Study or subgroup Phacoemulsification ECCE
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Katsimpris 2004 (1) 5/47 18/47 35.7 % 0.23 [ 0.09, 0.58 ]
MEHOX 2004 (2) 12/245 22/232 64.3 % 0.50 [ 0.25, 1.01 ]
Total (95% CI) 292 279 100.0 % 0.38 [ 0.22, 0.66 ]
Total events: 17 (Phacoemulsification), 40 (ECCE)
Heterogeneity: Chi2 = 1.76, df = 1 (P = 0.18); I2 =43%
Test for overall effect: Z = 3.41 (P = 0.00065)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours phaco Favours ECCE
(1) At 14 months
(2) Laser capsulotomy
Analysis 1.11. Comparison 1 Phacoemulsification versus ECCE, Outcome 11 Retinal detachment.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 11 Retinal detachment
Study or subgroup Phacoemulsification ECCE
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
MEHOX 2004 2/245 0/232 7.04 [ 0.44, 112.93 ]
0.01 0.1 1 10 100
Favours phaco Favours ECCE
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Analysis 1.12. Comparison 1 Phacoemulsification versus ECCE, Outcome 12 Cystoid macular oedema.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 12 Cystoid macular oedema
Study or subgroup Phacoemulsification ECCE
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Katsimpris 2004 1/47 8/47 62.4 % 0.18 [ 0.05, 0.72 ]
MEHOX 2004 2/245 3/232 37.6 % 0.63 [ 0.11, 3.68 ]
Total (95% CI) 292 279 100.0 % 0.29 [ 0.10, 0.86 ]
Total events: 3 (Phacoemulsification), 11 (ECCE)
Heterogeneity: Chi2 = 1.19, df = 1 (P = 0.27); I2 =16%
Test for overall effect: Z = 2.24 (P = 0.025)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours phaco Favours ECCE
Analysis 1.13. Comparison 1 Phacoemulsification versus ECCE, Outcome 13 Iris prolapse.
Review: Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-
related cataract
Comparison: 1 Phacoemulsification versus ECCE
Outcome: 13 Iris prolapse
Study or subgroup Phacoemulsification ECCE
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
MEHOX 2004 0/246 17/236 0.12 [ 0.05, 0.32 ]
0.01 0.1 1 10 100
Favours phaco Favours ECCE
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Analysis 1.14. Comparison 1 Phacoemulsification versus ECCE, Outcome 14 Other complications.
Other complications
Study Complication Result
Chee 1999 “Complications” None reported
George 2005 Mean induced astigmatism in dioptres (SD) Phacoemulsification (n = 60): 0.77 (0.65), ECCE (n =
52): 1.77 (1.65)
Katsimpris 2004 Corneal oedema (no time point stated)
Transient IOP spike
IOL decentration
Phacoemulsification: 22/47 (47%), ECCE: 35/47
(74%)
Phacoemulsification: 4/47 (9%), ECCE: 14/47 (30%)
Phacoemulsification: 0/47 (0%), ECCE: 2/47 (4%)
Landau 1999 Complications Phacoemulsification: 0/18 (0%), ECCE: 0/17 (0%)
Laurell 1998 Median diffusion coefficient for fluorescein leakage
through the BAB at 3 months
Phacoemulsification (n = 18): 8.58, ECCE (n = 17): 14.
34
MEHOX 2004 Endophthalmitis Phacoemulsification: 3/245 (1%), ECCE: 1/232 (0.
4%)
A D D I T I O N A L T A B L E S
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Table 1. Outcome reporting matrix (Continued)
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√
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erative
inflam-
mation
√
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√
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√
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√
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√ √
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√
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Table 1. Outcome reporting matrix (Continued)
tion for fluo-
rescein
leakage
through
BAB
difficul-
ties, cost
√
Reported and included in review.
Other codes see Appendix 9.
BAB: blood-aqueous barrier
BCVA: best corrected visual acuity
IOL: intraocular lens
VA: visual acuity
Table 2. Corneal thickness
Díaz-Valle 1998 Mean change in corneal thickness (µm)
- at 3 months
Phacoemulsification (n = 20): 5 ECCE (n = 20 CCC, n
= 20 letterbox) 24 and 15
Laurell 1998 Mean increase in corneal thickness (µm)
- at day 3
Phacoemulsification (n = 20): 29 ECCE (n = 20): 29
Laurell 1998 Mean increase in corneal thickness (µm)
- 3 months
Phacoemulsification (n = 19): -4 ECCE (n = 20): 3
Ravalico 1997 Corneal thickness (% increase)
- at 7 days
Phacoemulsification (n = 20): 2.1 ECCE (n = 20): 6.4
Ravalico 1997 Corneal thickness (% increase)
- at 30 days
Phacoemulsification (n = 20) 0.8: ECCE (n = 20): 4.8
Ravalico 1997 Mean (SD) change in corneal thickness
- at 7 days
Phacoemulsification (n = 20) 11.6 (10.5): ECCE (n =
20): 34.7 (12.5)
Ravalico 1997 Mean (SD) change in corneal thickness
- at 30 days
Phacoemulsification (n = 20) 4.7 (10.3): ECCE (n = 20)
: 26.3 (12.2)
Stumpf 2006 Mean corneal thickness increase
- 1 month
Phacoemulsification (n = 20):7 ECCE (n = 21): 7
Stumpf 2006 Mean corneal thickness increase
- 3 months from baseline
Phacoemulsification (n = 20): 0 ECCE (n = 21): 1
Stumpf 2006 Mean corneal thickness increase
- 6 months from baseline
Phacoemulsification (n = 20): 3 ECCE (n = 21): 5
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Cataract
#2 MeSH descriptor Cataract Extraction
#3 MeSH descriptor Lens, Crystalline
#4 MeSH descriptor Lenses, Intraocular
#5 MeSH descriptor Lens Implantation, Intraocular
#6 intraocular lens* or intra ocular lens* or IOL*
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)
#8 MeSH descriptor Phacoemulsification
#9 pha?oemulsif*
#10 phaco or phako
#11 (#8 OR #9 OR #10)
#12 extracapsular near/2 cataract
#13 extra capsular near/2 cataract
#14 ECCE
#15 (#12 OR #13 OR #14)
#16 (#7 AND #11 AND #15)
Appendix 2. MEDLINE (OvidSP) search strategy
1. randomized controlled trial.pt.
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. exp animals/
10. exp humans/
11. 9 not (9 and 10)
12. 8 not 11
13. exp cataract/
14. cataract extraction/
15. exp lens crystalline/
16. exp lenses intraocular/
17. lens implantation intraocular/
18. (intraocular lens$ or intra ocular lens$ or IOL$).tw.
19. or/13-18
20. phacoemulsification/
21. pha?oemulsif$.tw.
22. (phaco or phako).tw.
23. or/20-22
24. (extracapsular adj2 cataract$).tw.
25. (extra capsular adj2 cataract$).tw.
26. ECCE.tw.
27. or/24-26
28. 19 and 23 and 27
29. 12 and 28
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville et al (Glanville 2006).
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Appendix 3. EMBASE.com search strategy
1. exp randomized controlled trial/
2. exp randomization/
3. exp double blind procedure/
4. exp single blind procedure/
5. random$.tw.
6. or/1-5
7. (animal or animal experiment).sh.
8. human.sh.
9. 7 and 8
10. 7 not 9
11. 6 not 10
12. exp clinical trial/
13. (clin$ adj3 trial$).tw.
14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15. exp placebo/
16. placebo$.tw.
17. random$.tw.
18. exp experimental design/
19. exp crossover procedure/
20. exp control group/
21. exp latin square design/
22. or/12-21
23. 22 not 10
24. 23 not 11
25. exp comparative study/
26. exp evaluation/
27. exp prospective study/
28. (control$ or prospectiv$ or volunteer$).tw.
29. or/25-28
30. 29 not 10
31. 30 not (11 or 23)
32. 11 or 24 or 31
33. exp cataract/
34. exp cataract extraction/
35. exp lens/
36. exp lens implant/
37. exp lens implantation/
38. (intraocular lens$ or intra ocular lens$ or IOLS).tw.
39. or/33-38
40. exp phacoemulsification/
41. pha?oemulsif$.tw.
42. (phaco or phako).tw.
43. or/40-42
44. exp extracapsular cataract extraction/
45. (extracapsular adj2 cataract$).tw.
46. (extra capsular adj2 cataract$).tw.
47. ECCE.tw.
48. or/44-47
49. 39 and 43 and 48
50. 32 and 49
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Appendix 4. LILACS search strategy
cataract$ and phaco$ or phako$ and extracapsular or extra capsular or ECCE
Appendix 5. Web of Science CPCI-S search strategy
#8 #3 and #6 and #7
#7 TS= (extracapsular or extra capsular or ECCE)
#6 #4 or #5
#5 TS=(phaco or phako)
#4 TS=(phacoemulsification or phakoemulsification)
#3 #1 OR #2
#2 TS=(intraocular lens* or intra ocular lens* or IOL*)
#1 TS=cataract*
Appendix 6. metaRegister of Controlled Trials search strategy
cataract AND phacoemulsification
Appendix 7. ClinicalTrials.gov search strategy
cataract AND phacoemulsification
Appendix 8. ICTRP search strategy
phacoemulsification = Condition AND extracapsular or extra capsular or ECCE = Intervention
Appendix 9. ORBIT classification
The Outcome Reporting Bias In Trials (ORBIT) study classification system for missing or incomplete outcome reporting in
reports of randomised trials as given in Kirkham 2010.
Description Level of reporting Risk of bias
Clear that the outcome was measured and analysed
A Trial report states that outcome was
analysed but only reports that result
was not significant (typically stating P
> 0.05)
Partial High risk
B Trial report states that outcome was
analysed but only reports that result
was significant (typically stating P <
0.05)
Partial No risk
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(Continued)
C Trial report states that outcome was
analysed but insufficient data were
presented for the trial to be included
in meta-analysis or to be considered
to be fully tabulated
Partial Low risk
D Trial report states that outcome was
analysed but no results reported
None High risk
Clear that the outcome was measured
E Clear that outcome was measured but
not necessarily analysed. Judgement
says likely to have been analysed but
not reported because of non-signifi-
cant results
None High risk
F Clear that outcome was measured but
not necessarily analysed. Judgement
says unlikely to have been analysed
but not reported because of non-sig-
nificant results
None Low risk
Unclear whether the outcome was measured
G Not mentioned but clinical judge-
ment says likely to have been mea-
sured and analysed but not reported
on the basis of non-significant results
None High risk
H Not mentioned but clinical judge-
ment says unlikely to have been mea-
sured at all
None Low risk
Clear that the outcome was not measured
I Clear that outcome was not measured NA No risk
C O N T R I B U T I O N S O F A U T H O R S
Conceiving the review: YR
Designing the review: YR, JE
Co-ordinating the review: YR, JE
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Data collection for the review:
- Designing electronic search strategies: Cochrane Eyes and Vision Group editorial base
- Undertaking manual searches: YR
- Screening search results: YR, SdeS
- Organising retrieval of papers: YR
- Screening retrieved papers against inclusion criteria: YR, SdeS
- Appraising quality of papers: YR, JE, SdeS
- Extracting data from papers: YR, JE, SdeS
- Writing to authors of papers for additional information: YR, SdeS
- Obtaining and screening data on unpublished studies: YR
Data management for the review:
- Entering data into RevMan: YR, SdeS
Analysis of data: YR, JE, SdeS
Interpretation of data:
- Providing a methodological perspective: JE
- Providing a clinical perspective: YR, SdeS
- Providing a policy perspective: YR, SdeS
Writing the review: YR, JE, SdeS
Performing previous work that was the foundation of the current study: YR, JE
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
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External sources
• Sightsavers, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The primary visual acuity (VA) outcomes for this review were presenting VA of 6/12 or better, or a best corrected VA of worse than 6/
60. None of the papers documented presenting VA, and therefore we report both uncorrected and best-corrected VA.
N O T E S
The original published Cochrane review ’Riaz Y, Mehta JS, Wormald R, Evans JR, Foster A, Ravilla T, Snellingen T. Surgical in-
terventions for age-related cataract. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001323. DOI: 10.1002/
14651858.CD001323.pub2’ has been divided into three smaller reviews each using the same outcome measures as the original review
but only comparing two surgical methods within each review. The interventions being compared are ECCE, MSICS and phacoemulsi-
fication. Intracapsular extraction (ICCE) is no longer included in the reviews as this technique is no longer used as a primary procedure.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Lenses, Intraocular; Cataract Extraction [adverse effects; ∗methods]; Clinical Protocols; Phacoemulsification [adverse effects;
∗methods]; Posterior Eye Segment [injuries]; Randomized Controlled Trials as Topic
MeSH check words
Aged; Aged, 80 and over; Humans; Middle Aged
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